[go: up one dir, main page]

WO2011135058A3 - Methods for detecting epigenetic modifications - Google Patents

Methods for detecting epigenetic modifications Download PDF

Info

Publication number
WO2011135058A3
WO2011135058A3 PCT/EP2011/056797 EP2011056797W WO2011135058A3 WO 2011135058 A3 WO2011135058 A3 WO 2011135058A3 EP 2011056797 W EP2011056797 W EP 2011056797W WO 2011135058 A3 WO2011135058 A3 WO 2011135058A3
Authority
WO
WIPO (PCT)
Prior art keywords
sample
gene
methylation status
dna
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2011/056797
Other languages
French (fr)
Other versions
WO2011135058A2 (en
Inventor
Joost Louwagie
Gaetan Otto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MDxHealth SA
Original Assignee
MDxHealth SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MDxHealth SA filed Critical MDxHealth SA
Publication of WO2011135058A2 publication Critical patent/WO2011135058A2/en
Publication of WO2011135058A3 publication Critical patent/WO2011135058A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method of determining the methylation status of a gene, in particular at least SYNE1 in a sample, such as a blood sample, in particular a blood plasma or serum sample, comprises the following steps: (a) isolating DNA from the sample (which may be a blood sample, in particular a plasma or serum sample) (b) subjecting the isolated DNA to treatment with a reagent which selectively modifies unmethylated cytosine residues in the DNA contained in the sample to produce detectable modified residues but which does not modify methylated cytosine residues (c) amplifying both treated isolated DNA strands. Amplification occurs in a manner that investigates the methylation status of both DNA strands. Detection of amplification products may be indicative of the methylation status of the gene, in particular the SYNE1 gene. The methods may be useful diagnostically, for example to indicate cancer in a sample. Various kits, primers and probes are also provided.
PCT/EP2011/056797 2010-04-30 2011-04-28 Methods for detecting epigenetic modifications Ceased WO2011135058A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32998210P 2010-04-30 2010-04-30
US61/329,982 2010-04-30

Publications (2)

Publication Number Publication Date
WO2011135058A2 WO2011135058A2 (en) 2011-11-03
WO2011135058A3 true WO2011135058A3 (en) 2012-09-13

Family

ID=44279944

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/056797 Ceased WO2011135058A2 (en) 2010-04-30 2011-04-28 Methods for detecting epigenetic modifications

Country Status (1)

Country Link
WO (1) WO2011135058A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104062334A (en) * 2014-07-11 2014-09-24 福州大学 Quantitative analysis method aiming at DNA methylation monitoring
EP3682028A1 (en) * 2017-09-15 2020-07-22 Clinical Genomics Pty Ltd Method for methylation analysis
TWI791347B (en) * 2020-12-11 2023-02-01 酷氏基因生物科技股份有限公司 A predictive methoh for assessing the success of embryo implantation
CN113552191B (en) * 2021-07-28 2023-11-21 江苏师范大学 Construction method of proportional electrochemical sensor for detecting methylated DNA based on multilayer DNA amplification loop
CN113667726A (en) * 2021-08-31 2021-11-19 重庆医科大学国际体外诊断研究院 DNAzyme and three-way junction-mediated isothermal amplification reaction for detecting site-specific m6A

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077272A2 (en) * 2001-03-26 2002-10-03 Epigenomics Ag Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
WO2008100913A2 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
WO2010089538A2 (en) * 2009-02-03 2010-08-12 Oncomethylome Sciences Sa Methods of detecting colorectal cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4437975A (en) 1977-07-20 1984-03-20 Mobil Oil Corporation Manufacture of lube base stock oil
CA1340843C (en) 1987-07-31 1999-12-07 J. Lawrence Burg Selective amplification of target polynucleotide sequences
KR0148265B1 (en) 1988-12-16 1998-10-15 에프.지이.엠 헤르만스 Self-Continuous Sequence Replication System
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
WO2004067726A2 (en) 2003-01-29 2004-08-12 Keck Graduate Institute Isothermal reactions for the amplification of oligonucleotides
PT1871912E (en) 2005-04-15 2012-05-25 Epigenomics Ag Method for determining dna methylation in blood or urine samples
US20070141582A1 (en) 2005-12-15 2007-06-21 Weiwei Li Method and kit for detection of early cancer or pre-cancer using blood and body fluids
GB0700374D0 (en) 2007-01-09 2007-02-14 Oncomethylome Sciences S A NDRG family methylation markers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002077272A2 (en) * 2001-03-26 2002-10-03 Epigenomics Ag Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
WO2008100913A2 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
WO2010089538A2 (en) * 2009-02-03 2010-08-12 Oncomethylome Sciences Sa Methods of detecting colorectal cancer

Also Published As

Publication number Publication date
WO2011135058A2 (en) 2011-11-03

Similar Documents

Publication Publication Date Title
WO2011142836A3 (en) Assays for the detection of genotype, mutations, and/or aneuploidy
WO2013017853A3 (en) Methods for detection of nucleotide modification
AU2019213047A1 (en) CRISPR effector system based diagnostics
PH12015500430A1 (en) Method for screening cancer
WO2008087040A3 (en) Methods and nucleic acids for analyses of cell proliferative disorders
WO2012067830A3 (en) Methylation assay
NZ596545A (en) Improved detection of mage-a expression
WO2010089538A9 (en) Methods of detecting colorectal cancer
NZ598166A (en) Methods, primers, probes and kits useful for the detection of braf mutations
WO2009149026A3 (en) Genomic approaches to fetal treatment and diagnosis
WO2013148147A8 (en) Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
WO2009074328A8 (en) Methods and nucleic acids for analyses of lung carcinoma
WO2009153667A3 (en) Method for the detection of ovarian cancer
WO2008054556A3 (en) Methods and compositions for detection of a target nucleic acid sequence
WO2008134596A3 (en) Use of methylated or unmethylated line-i dna as a cancer marker
WO2007110656A3 (en) Methods and apparatus for genotyping
WO2010096202A3 (en) Sequence-specific detection of nucleotide sequences
WO2009143500A3 (en) Methods for removing nucleic acid contamination from reagents
EP2254897A4 (en) Methods, reagents and kits for detection of nucleic acid molecules
WO2011135058A3 (en) Methods for detecting epigenetic modifications
WO2009097511A3 (en) Two stage enrichment of cell-free fetal dna in maternal plasma
WO2013090386A3 (en) Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample
WO2008063655A3 (en) Dna methylation markers and methods of use
WO2011104695A3 (en) Detection of kras mutation in exon 2 by allele specific real time quantitative pcr (as-qpcr)
WO2010007083A3 (en) Methods and nucleic acids for analyses of cell proliferative disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11728193

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11728193

Country of ref document: EP

Kind code of ref document: A2